jack west and julia rotow discuss adaura trial takeaways
Published 1 year ago • 242 plays • Length 10:50Download video MP4
Download video MP3
Similar videos
-
11:12
for nsclc neoadjuvant adjuvant or both
-
1:17:52
egfr initial treatment, acquired resistance and q&a with h. jack west, md and helena yu, md
-
5:08
should adaura trial results change practice in nsclc?
-
16:41
asco lung cancer roundtable - trial updates in nsclc - adaura trial and post surgery egfr mutation
-
5:54
key points from the adaura trial: osimertinib - targeted therapies in lung cancer 2023
-
6:26
the adaura trial: the effect on egfr treatment
-
8:46
today immunotherapy can cure even fourth stage cancer: dr dattatreyudu nori
-
13:52
lung cancer stage 4 update: 8months after taking tagrisso - tumor pills
-
25:31
adaura trial adjuvant osimetrinib
-
29:45
immunotherapy in lung cancer with dr. jack west, part 1
-
5:12
adaura trial: tagrisso & resectable egfr - leading developments & current questions in lung cancer
-
4:35
what is a standard adjuvant chemotherapy regimen?
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
6:39
recurrance of diseases
-
5:18
jill feldman ma med discussing the adaura trial
-
7:00
researcher comment: dual egfr inhibition for egfr-mutated nsclc | julia rotow
-
29:06
q & a with dr's. riely, weiss and sequist; moderated by dr. west
-
11:20
the oncology brothers discuss adaura trial findings
-
1:10
grateful for another great year
-
1:20
dr. julia white on determining risk in patients with breast cancer
-
8:58
the adaura study/ osimertinib: how cheerleaders fail patients